Cytotoxic and apoptotic activities in selected phyllanthaceae species of Malaysia / Sujatha a/p Ramasamy by Ramasamy, Sujatha
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APPENDIX 1
Preparations of Solutions and Reagents
Cell Culture
Preparation of Media and Solutions
Basic DMEM Media
One sachet of DMEM powder (Sigma-Aldrich, USA) that containing Earle’s salt
with L-Glutamine and HEPES (N-2-Hydroxylethyl-Piperazine-N-2-Ethane-Sulfonoc Acid,
(Sigma-Aldrich, USA) without sodium bicarbonate (BDH AnalaR, UK) was made up to 1
liter with distilled water. Two grams of sodium bicarbonate (NaHCO3, Merck, Germany)
was added to the media. The media was filter sterilized using a 0.22 m filter membrane
(Orange Scientific) and stored at 4 °C for up to 4 months.
Basic RPMI 1640 Media
Media was prepared by dissolving 10.39 g of RPMI 1640 powder (Sigma-Aldrich,
USA) and 2.0 g of sodium bicarbonate in 1 liter of distilled water. The pH of the media was
calibrated to pH 7.4 (Thermo Scientific). The media was then filter sterilized through a 0.2
m filter membrane (Orange Scientific) into sterile bottles and kept at 4 °C.
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10 % Supplemented DMEM Media and RPMI 1640 Media
One hundred milliliters of 10 % supplemented DMEM media and RPMI 1640
media were prepared using 90 ml of basic media, supplemented with 10 ml inactivated
Foetal Bovine Serum (FBS, PAA Lab. Austria), 1 ml (100 g/ml) and 1 ml (100 IU/ml) of
streptomycin and penicillin (PAA Lab. Austria) respectively and 1 ml of fungizone (PAA
Lab. Austria). The media was filter sterilized using a 0.22 m filter membrane and stored at
4 °C for up to 2 weeks.
20 % Supplemented DMEM and RPMI 1640 Media
Fifty milliliters of 20 % supplemented DMEM media or RPMI 1640 media was
prepared using 45 ml of 10 % supplemented media was added with 5 ml inactivated FBS.
The media was filter sterilized using a 0.22 m filter membrane and stored at 4 °C for up to
2 weeks. This 20 % supplemented media was used to revive cells.
Phosphate Buffered Saline (PBS) pH 7.2
The phosphate buffered saline (PBS) was prepared using 1.52 g of sodium
phosphate anhydrous (NaHPO4, Merck), 0.58 g of potassium dihydrogen orthophosphate
(KH2PO4, Merck) and 8.5 g of sodium chloride (BDH AnalaR, UK) that were dissolved in
distilled water and the volume was made up to 1 liter. The pH of the buffer was adjusted to
7.2 using a pH meter. The buffer was then filtered using a 0.22 m filter membrane and
stored at room temperature.
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Tryphan Blue Solution 0.4 %
0.2 g of tryphan blue powder was dissolved in 50 ml of distilled water.
Bioassay-guided Fractionation
Thin Layer Chromatography
Anisaldehyde-Sulphuric Acid Reagent (AS)
85 ml of methanol (Fisher Scientific), 10 ml of acetic acid glacial (BDH AnalaR,
UK) and 5 ml of sulphuric acid concentrated (H2SO4) (Fisher Scientific) were added to 0.5
ml of anisaldehyde solution (Sigma-Aldrich, USA).
Neutral Red Cytotoxicity Activity Assay
Preparation of Solutions
Neutral Red Stock Solution
0.4 g of Neutral Red (ICN, USA) was dissolved in 100 ml distilled water. The
solution was kept at 4 °C.
Neutral Red Medium
The Neutral Red stock solution was diluted (1׃80) in treatment culture medium to
give a final concentration of 50 g/ml. Prepared Neutral Red medium were incubated
219
overnight at room temperature in the dark. This solution was centrifuged twice at 1500 g
for 10 min. before use to remove any fine, needle-like precipitate of dye crystals.
Neutral Red Washing Solution
10% of calcium chloride (Sigma) was dissolved in 1ml formaldehyde (Sigma) and
89 ml of distilled water. The solution was kept at 4ºC.
Neutral Red Resorb Solution
1 ml of glacial acetic acid (BDH AnalaR, UK) was dissolved in 50 ml of absolute
ethanol (Hamburg) and 49 ml of distilled water. The solution was kept at 4 °C.
Apoptosis assay
Preparation of Buffer and Solutions
Acridine orange / ethdium bromide (AO/EB) fluorescence staining
Acridine orange / ethdium bromide (AO/EB)
Individual stock solutions of acridine orange (AO; Sigma-Aldrich, USA) and
ethidium bromide (EB; Sigma-Aldrich, USA) were prepared in distilled water at a
concentration of 1 mg/ml. Stock solutions were stored at 4 °C for up to 12 months and
protected from light
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For use in assays, working solutions of 100 µg/ml of AO + 100 µg/ml of EB (AO +
EB) were prepared in distilled water. Working solutions were stored at 4 °C and protected
from light.
50 × TAE electrophoresis buffer; pH ~ 8.5
242.0 g og Tris base, 57.1 ml of glacial acetic acid and 37.2 g of EDTA (Sigma-
Aldrich, USA) were dissolved in 1 L of sterile distilled water. The pH of the buffer was
adjusted to approximately 8.5 using a pH meter (Thermo Scientific). The solution was kept
at room temperature.
1 × TAE running buffer
20 ml of 50 × TAE stock solutions was mix with 980 ml of sterile distilled water.
The solution was kept at room temperature.
1.5 % agarose
1.5 % of agarose was added to 100 ml of 1 × TAE running buffer. The solution was
heated in microwave until dissolved and kept at room temperature.
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Phosphate Buffered Saline (PBS) (10х stock solution); pH 7.4
80 g of NaCl, 2 g of KCl, 11.5 g of Na2HPO4.7H2O and 2 g of KH2PO4 were
dissolved in 1 L of distilled water. The pH of the buffer was adjusted to 7.4 using a pH
meter (Thermo Scientific). The solution was kept at room temperature.
Phosphate Buffered Saline (PBS) (1х working solution); pH 7.4
137 mM of NaCl, 2.7 mM of KCl, 4.3 mM of Na2HPO4.7H2O and 1.4 mM of
KH2PO4 were prepared.
Lysis Buffer
5 ml of 1 M Tris-HCl, 4 ml of 0.5 M EDTA (Sigma-Aldrich, USA), 1.43 ml of
Tergitol® solution Type NP-40 (Sigma-Aldrich, USA) and 20 µl of SDS 10 % were
dissolved in distilled water. Solution was kept at 4 °C for up to 2 months.
SDS solution 10 %
10 g of SDS powder were dissolved in 100 ml of distilled water. Solution was kept
at room temperature.
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1 M TRIS-HCl pH 8.0
15.76 g of Tris-Hcl powder were dissolved in 100 ml of distilled water and the pH
was adjusted to 8.0 using a pH meter (Thermo Scientific). The solution was kept at room
temperature.
8 M potassium acetate solution
7.8512 g of potassium acetate powder were dissolved in 10 ml of distilled water.
Solution was kept at room temperature.
0.5 M EDTA solution pH 8.0
18.612 g EDTA powder were dissolved in 100 ml of distilled water and the pH was
adjusted to 8.0 using a pH meter (Thermo Scientific). The solution was kept at 4ºC.
TE Buffer
1000 µl of Tris-HCl 1M (pH 8.0) were added with 200 µl of 0.5M EDTA solution
(pH 8.0) and were dissolved in 98.8 ml of distilled water. The solution was kept at room
temperature.
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Ethidium bromide stock 0.01 mg/ml
0.01 g of ethidium bromide powder were dissolved in 1 ml of distilled water and
kept in dark.
Ethidium bromide solution
30 µl of ethidium bromide stock were dissolved in 300 ml of distilled water and
kept in dark.
Caspase-3/CPP32 colorimetric assay
2 × reaction buffer (containing 10 mM DTT)
10 µl of 1.0 M DTT was dissolved in 1.0 ml 0f 2 × reaction buffer.
CycleTESTTM PLUS DNA Reagent Kit
Solution A
Solution A contains trypsin in a spermine tetrahydrochloride detergent buffer for




Solution B contains trypsin inhibitor and ribonuclease A in citrate-stabilizing buffer
with spermine tetrahydrochloride to inhibit the trypsin activity and to digest the RNA.
Solution C
Solution C contains propidium iodide (PI) and spermine tetrahydrochloride in
citrate stabilizing buffer. The PI stoichiometrically binds to the DNA at a final
concentration of at least 125 µg/ml.
Solution D
Solution D contains sodium citrate, sucrose and dimethyl sulfoxide (DMSO) for the
collection and/or freezing of cell suspensions.
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APPENDIX 2
Cytotoxic activity raw data
Cytotoxic activity of Phyllanthaceae species crude extracts on various human cancer
cell lines
IC50 values (µg/ml) of Phyllanthaceae crude extracts on MCF7 cell line
IC50 values (µg/ml)
Crude extracts Test 1 Test 2 Test 3 Average
P. niruri (CME) 66.1 60.5 58.5 61.7 ± 3.94
P. niruri (CHE) 74.0 77.0 74.0 75.0 ± 1.73
P. niruri (CEE) 32.9 32.5 28.0 31.1 ± 2.72
P. pectinatus –Leaves(CME) 62.0 60.0 58.5 60.2 ± 1.76
P. pectinatus –Leaves(CHE) >100 >100 >100 >100
P. pectinatus -Leaves(CEE) 46.0 51.5 54.0 50.5 ± 4.09
P. pectinatus –Fruits(CME) 54.0 49.0 50.0 51.0 ± 2.65
P. pectinatus –Fruits(CHE) >100 >100 >100 >100
P. pectinatus -Fruits(CEE) 17.5 18.8 18.0 18.1 ± 0.66
P. acidus (CME) >100 >100 >100 >100
P. acidus (CHE) 92.0 93.5 105.0 96.8 ± 7.11
P. acidus (CEE) 37.0 43.0 52.5 44.2 ± 7.82
P. roseus (CME) 34.0 42.5 43.5 40.0 ± 5.22
P. roseus (CHE) 46.0 54.5 62.5 54.3 ± 8.25
P. roseus (CEE) 20.5 22.5 31.0 24.7 ± 5.58
P. watsonii (CME) 9.5 10.5 18.0 12.7 ± 4.65
P. watsonii (CHE) 8.0 7.3 8.5 7.9 ± 0.60
P. watsoniii (CEE) 8.0 7.5 7.5 7.7 ± 0.29
B. motleyana (CME) 57.5 61.2 63.0 60.6 ± 2.80
B. motleyana (CHE) 88.0 94.0 98.5 93.5 ± 5.27
B. motleyanai (CEE) 86.5 92.5 88.0 89.0 ± 3.12
Doxorubicin (positive control) 0.70 0.75 0.70 0.72 ± 0.03
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IC50 values (µg/ml) of Phyllanthaceae crude extracts on SKOV3 cell line
IC50 values (µg/ml)
Crude extracts Test 1 Test 2 Test 3 Average
P. niruri (CME) 29.0 47.0 46.5 40.8 ± 8.29
P. niruri (CHE) 47.0 57.0 47.5 50.5 ± 5.63
P. niruri (CEE) 31.5 34.5 34.0 33.3 ± 1.61
P. pectinatus –Leaves(CME) 4.0 6.0 4.5 4.8 ± 1.04
P. pectinatus –Leaves(CHE) 46.5 62.5 48.0 52.3 ± 8.84
P. pectinatus -Leaves(CEE) 6.5 5.0 6.0 5.8 ± 0.76
P. pectinatus –Fruits(CME) >100 >100 >100 >100
P. pectinatus –Fruits(CHE) >100 >100 >100 >100
P. pectinatus -Fruits(CEE) 68.5 85.0 53.5 69.0 ± 15.76
P. acidus (CME) 82.0 91.5 93.0 88.8 ± 5.97
P. acidus (CHE) 71.5 87.5 83.5 80.8 ± 8.33
P. acidus (CEE) 64.0 68.5 71.0 67.8 ± 3.55
P. roseus (CME) >100 >100 >100 >100
P. roseus (CHE) >100 >100 >100 >100
P. roseus (CEE) >100 >100 >100 >100
P. watsonii (CME) 8.0 9.0 8.5 8.5 ± 0.50
P. watsonii (CHE) 6.0 6.0 5.5 5.8 ± 0.29
P. watsoniii (CEE) 5.0 5.5 6.0 5.5 ± 0.50
B. motleyana (CME) >100 >100 >100 >100
B. motleyana (CHE) >100 >100 >100 >100
B. motleyanai (CEE) >100 >100 >100 >100
Doxorubicin (positive control) 0.15 0.60 0.50 0.42 ± 0.24
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IC50 values (µg/ml) of Phyllanthaceae crude extracts on CaSki cell line
IC50 values (µg/ml)
Crude extracts Test 1 Test 2 Test 3 Average
P. niruri (CME) 79.5 83.5 89.0 84.0 ± 4.77
P. niruri (CHE) >100 >100 >100 >100
P. niruri (CEE) 53.5 52.5 52.5 52.8 ± 0.58
P. pectinatus –Leaves(CME) 93.0 95.0 97.0 95.0 ± 2.00
P. pectinatus –Leaves(CHE) >100 >100 >100 >100
P. pectinatus -Leaves(CEE) 41.5 47.5 42.5 43.8 ± 3.21
P. pectinatus –Fruits(CME) 72.5 71.0 76.5 73.3 ± 2.84
P. pectinatus –Fruits(CHE) >100 >100 >100 >100
P. pectinatus -Fruits(CEE) 19.0 19.2 20.0 19.4 ± 0.53
P. acidus (CME) >100 >100 >100 >100
P. acidus (CHE) 81.0 76.5 92.5 83.8 ± 8.25
P. acidus (CEE) 65.0 63.0 38.5 55.5 ± 14.76
P. roseus (CME) >100 >100 >100 >100
P. roseus (CHE) 49.5 73.0 55.0 59.2 ± 12.29
P. roseus (CEE) 71.5 94.0 83.5 83.0 ± 11.26
P. watsonii (CME) 7.5 9.0 7.5 8.0 ± 0.87
P. watsonii (CHE) 6.2 6.5 8.0 6.9 ± 0.96
P. watsoniii (CEE) 3.7 4.5 2.5 3.6 ± 1.01
B. motleyana (CME) >100 >100 >100 >100
B. motleyana (CHE) >100 >100 >100 >100
B. motleyanai (CEE) >100 >100 >100 >100
Doxorubicin (positive control) 0.60 0.70 0.75 0.68 ± 0.08
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IC50 values (µg/ml) of Phyllanthaceae crude extracts on HT29 cell line
IC50 values (µg/ml)
Crude extracts Test 1 Test 2 Test 3 Average
P. niruri (CME) 92.5 97.5 96.5 95.5 ± 2.65
P. niruri (CHE) 77.5 107.0 110.0 98.2 ± 17.96
P. niruri (CEE) 76.0 79.5 83.5 79.7 ± 3.75
P. pectinatus –Leaves(CME) 35.7 49.0 32.5 39.1 ± 8.75
P. pectinatus –Leaves(CHE) >100 >100 >100 >100
P. pectinatus -Leaves(CEE) 30.5 24.5 29.5 28.2 ± 3.21
P. pectinatus –Fruits(CME) >100 >100 >100 >100
P. pectinatus –Fruits(CHE) >100 >100 >100 >100
P. pectinatus -Fruits(CEE) 67.5 61.0 56.0 61.5 ± 5.77
P. acidus (CME) >100 >100 >100 >100
P. acidus (CHE) >100 >100 >100 >100
P. acidus (CEE) 67.5 73.0 59.0 66.5 ± 7.05
P. roseus (CME) 64.5 52.5 63.0 60.0 ± 6.54
P. roseus (CHE) 64.0 63.0 49.0 58.7 ± 8.39
P. roseus (CEE) 80.0 87.0 100.0 89.0 ± 10.15
P. watsonii (CME) 20.0 17.0 18.0 18.3 ± 1.53
P. watsonii (CHE) 13.0 12.5 10.0 11.8 ± 1.61
P. watsoniii (CEE) 4.8 5.0 5.5 5.1 ± 0.36
B. motleyana (CME) 62.0 54.5 64.5 60.3 ± 5.20
B. motleyana (CHE) >100 >100 >100 >100
B. motleyanai (CEE) >100 >100 >100 >100
Doxorubicin (positive control) 0.65 0.65 0.60 0.63 ± 0.03
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Cytotoxic activity of Phyllanthaceae species crude extracts on human normal cell line
IC50 values (µg/ml) of Phyllanthaceae crude extracts on MRC5 cell line
IC50 values (µg/ml)
Crude extracts Test 1 Test 2 Test 3 Average
P. niruri (CME) 101.0 95.0 100.5 98.8 ± 3.33
P. niruri (CHE) >100 >100 >100 >100
P. niruri (CEE) >100 >100 >100 >100
P. pectinatus –Leaves(CME) >100 >100 >100 >100
P. pectinatus –Leaves(CHE) >100 >100 >100 >100
P. pectinatus -Leaves(CEE) >100 >100 >100 >100
P. pectinatus –Fruits(CME) >100 >100 >100 >100
P. pectinatus –Fruits(CHE) >100 >100 >100 >100
P. pectinatus -Fruits(CEE) 77.5 104.0 90.0 90.5 ± 13.26
P. acidus (CME) >100 >100 >100 >100
P. acidus (CHE) >100 >100 >100 >100
P. acidus (CEE) >100 >100 >100 >100
P. roseus (CME) >100 >100 >100 >100
P. roseus (CHE) 65.0 58.0 66.0 63.0 ± 4.36
P. roseus (CEE) >100 >100 >100 >100
P. watsonii (CME) 56.0 46.5 45.5 49.3 ± 5.80
P. watsonii (CHE) 58.5 63.5 60.0 57.3 ± 2.57
P. watsoniii (CEE) 36.0 31.0 34.5 33.8 ± 2.57
B. motleyana (CME) >100 >100 >100 >100
B. motleyana (CHE) >100 >100 >100 >100
B. motleyanai (CEE) >100 >100 >100 >100
Doxorubicin (positive control) 1.80 1.65 1.70 1.72±0.08
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Cytotoxic activity of fractions of P. watsonii crude hexane extracts on various human
cancer cell lines
IC50 values (µg/ml) of fractions of P. watsonii  on MCF7 cell line
IC50 values (µg/ml)
Fractions Test 1 Test 2 Test 3 Average
PW1 >100 >100 >100 >100
PW2 >100 >100 >100 >100
PW3 84.0 96.5 91.0 90.5 ± 6.26
PW4 7.5 8.0 7.5 7.7 ± 0.29
PW5 7.5 8.0 7.5 7.7 ± 0.29
PW6 7.5 7.5 7.0 7.3 ± 0.29
PW7 6.5 8.5 7.0 7.3 ± 1.04
PW8 0.5 3.5 2.0 2.0 ± 1.50
PW9 >100 >100 >100 >100
PW10 >100 >100 >100 >100
Doxorubicin (positive control) 0.70 0.75 0.70 0.72 ± 0.03
IC50 values (µg/ml) of fractions of P. watsonii on SKOV3 cell line
IC50 values (µg/ml)
Fractions Test 1 Test 2 Test 3 Average
PW1 91.0 90.0 88.5 89.8 ± 1.25
PW2 7.0 7.0 6.5 6.8 ± 0.29
PW3 5.5 4.5 6.0 5.3 ± 0.76
PW4 0.3 0.2 0.3 0.3 ± 0.06
PW5 0.2 0.1 0.2 0.2 ± 0.06
PW6 0.3 0.5 0.5 0.4 ± 0.12
PW7 0.5 1.0 1.0 0.8 ± 0.29
PW8 0.5 0.3 0.5 0.4 ± 0.12
PW9 69.0 74.0 69.0 70.7 ± 2.89
PW10 >100 >100 >100 >100
Doxorubicin (positive control) 0.15 0.60 0.50 0.42 ± 0.24
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IC50 values (µg/ml) of fractions of P. watsonii on CaSki cell line
IC50 values (µg/ml)
Fractions Test 1 Test 2 Test 3 Average
PW1 >100 >100 >100 >100
PW2 >100 >100 >100 >100
PW3 87.0 82.0 87.5 85.5 ± 3.04
PW4 16.5 13.0 10.0 13.2 ± 3.25
PW5 8.5 6.5 6.5 7.2 ± 1.15
PW6 5.0 6.0 5.5 5.5 ± 0.50
PW7 8.5 9.5 8.5 8.8 ± 0.58
PW8 3.5 3.0 2.0 2.8 ± 0.76
PW9 >100 >100 >100 >100
PW10 >100 >100 >100 >100
Doxorubicin (positive
control)
0.60 0.70 0.75 0.68 ± 0.08
IC50 values (µg/ml) of fractions of P. watsonii on HT29 cell line
IC50 values (µg/ml)
Fractions Test 1 Test 2 Test 3 Average
PW1 >100 >100 >100 >100
PW2 >100 >100 >100 >100
PW3 64.5 68.5 66.0 66.3 ± 2.02
PW4 11.0 11.5 10.0 10.8 ± 0.76
PW5 4.5 5.0 6.0 5.2 ± 0.76
PW6 5.5 6.5 5.0 5.7 ± 0.76
PW7 2.0 0.5 2.5 1.2 ± 1.04
PW8 2.0 1.5 1.5 1.2 ± 0.29
PW9 >100 >100 >100 >100
PW10 >100 >100 >100 >100
Doxorubicin (positive control) 0.65 0.65 0.60 0.63 ± 0.03
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Cytotoxic activity of fractions of P. watsonii on human normal cell lines
IC50 values (µg/ml) of fractions of P. watsonii on MRC5 cell line
IC50 values (µg/ml)
Fractions Test 1 Test 2 Test 3 Average
PW1 >100 >100 >100 >100
PW2 >100 >100 >100 >100
PW3 >100 >100 >100 >100
PW4 16.5 18.0 14.5 16.3 ± 1.76
PW5 15.0 10.0 12.0 12.3 ± 2.52
PW6 6.0 8.0 7.5 7.8 ± 1.04
PW7 6.0 8.5 9.5 8.0 ± 1.80
PW8 7.5 8.0 9.5 8.3 ± 1.04
PW9 >100 >100 >100 >100
PW10 >100 >100 >100 >100
Doxorubicin (positive control) 1.80 1.65 1.70 1.72 ± 0.08
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Cytotoxic activity of fractions of P.watsonii on various human cancer cell lines
IC50 values (µg/ml) of fractions of P. watsonii on MCF7 cell line
IC50 values (µg/ml)
Fractions Test 1 Test 2 Test 3 Average
PPW1 >100 >100 >100 >100
PPW2 >100 >100 >100 >100
PPW3 >100 >100 >100 >100
PPW4 65.5 59.5 59.0 61.3 ± 3.62
PPW5 52.5 58.5 56.0 55.7 ± 3.01
PPW6 8.5 9.0 9.0 8.83 ± 0.29
PPW7 0.9 0.9 1.0 0.9 ± 0.06
PPW8 13.5 15.0 13.0 13.8 ± 1.04
Doxorubicin (positive control) 0.70 0.75 0.70 0.72 ± 0.03
IC50 values (µg/ml) of fractions of P. watsonii on SKOV3 cell line
IC50 values (µg/ml)
Fractions Test 1 Test 2 Test 3 Average
PPW1 105.0 100.0 100.0 100.0 ± 2.89
PPW2 >100 >100 >100 >100
PPW3 81.0 64.5 76.5 74.0 ± 8.53
PPW4 36.5 37.5 37.0 37.0 ± 0.50
PPW5 5.5 2.0 7.0 4.8 ± 2.57
PPW6 7.5 11.0 10.0 9.5 ± 1.80
PPW7 0.5 0.6 0.5 0.7 ± 0.06
PPW8 0.8 1.0 0.9 0.9 ± 0.10
Doxorubicin (positive control) 0.15 0.60 0.50 0.42 ± 0.24
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Cytotoxic activity of fractions of P. watsonii on various human cancer cell lines
IC50 values (µg/ml) of fractions of P. watsonii on CaSki cell line
IC50 values (µg/ml)
Fractions Test 1 Test 2 Test 3 Average
PPW1 >100 >100 >100 >100
PPW2 >100 >100 >100 >100
PPW3 96.5 100.0 100.0 98.8 ± 2.02
PPW4 61.5 61.5 57.0 60.0 ± 2.60
PPW5 47.0 47.0 41.5 45.2 ± 3.18
PPW6 12.0 15.5 8.5 12.0 ± 3.50
PPW7 0.8 0.8 0.8 0.8 ± 0.00
PPW8 9.5 9.5 8.5 9.2 ± 0.58
Doxorubicin (positive control) 0.60 0.70 0.75 0.68 ± 0.08
IC50 values (µg/ml) of fractions of P. watsonii on HT29 cell line
IC50 values (µg/ml)
Fractions Test 1 Test 2 Test 3 Average
PPW1 65.5 74.5 78.5 72.8±6.66
PPW2 >100 >100 >100 >100
PPW3 >100 >100 >100 >100
PPW4 41.5 38.5 42.5 40.8±2.08
PPW5 65.5 61.5 64.5 63.8±2.08
PPW6 17.5 17.0 10.0 14.8±4.19
PPW7 0.7 0.9 0.8 0.8±0.10
PPW8 15.5 21.0 18.5 18.3±2.75
Doxorubicin (positive control) 0.65 0.65 0.60 0.63±0.03
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Cytotoxic activity of fractions of P. watsonii on human normal cell line
IC50 values (µg/ml) of fractions of P. watsonii on MRC5 cell line
IC50 values (µg/ml)
Fractions Test 1 Test 2 Test 3 Average
PPW1 >100 >100 >100 >100
PPW2 >100 >100 >100 >100
PPW3 >100 >100 >100 >100
PPW4 >100 >100 >100 >100
PPW5 >100 >100 >100 >100
PPW6 12.5 15.0 16.0 14.5 ± 1.80
PPW7 9.0 11.5 10.0 10.2 ± 1.26
PPW8 15.5 17.0 18.0 16.8 ± 1.26















































































































































































Standard curves for BSA standards
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Activation of caspase-3 by cytotoxically active crude extracts and fractions of Phyllanthaceae species. Cells
were treated with 10 µg/ml crude extracts or fractions for 48 h. Cell lysates were applied to Caspase-3/CPP32
Colorimetric Assay Kit (BioVision) to detect specific caspase activity. The release of pNA was monitored
spectrometrically at 405 nm.
Caspase-3 activity ( % of control)Extracts /
Fractions Cell lines 1 2 3 Average
PPFE 165.9 165.9 156.8 162.9 ± 5.25
PWM 276.1 213.6 218.2 236.0 ± 34.83
PWH 195.5 161.4 188.6 181.8 ± 18.03
PWE 136.4 156.8 162.5 151.9 ± 13.72
PPW6 217.0 221.6 215.9 218.2 ± 3.02
PPW7 195.5 189.8 183.0 189.4 ± 6.26
Doxorubicin
MCF7
451.1 435.2 445.5 443.9 ± 8.06
PPLM 324.2 319.7 322.9 322.3 ± 2.32
PPLE 364.3 375.2 370.1 369.9 ± 5.45
PWM 357.3 358.0 345.2 353.5 ± 7.20
PWH 198.1 211.5 217.2 208.9 ± 9.81
PWE 300.0 301.3 287.9 296.4 ±  7.39
PPW6 232.5 231.2 231.2 231.6 ± 0.75
PPW7 190.4 180.3 189.2 186.6 ± 5.52
Doxorubicin
SKOV3
248.4 249.0 254.8 250.7 ± 3.53
PPFE 165.3 170.2 176.6 170.7 ± 5.67
PWM 167.7 161.3 175.0 168.0 ± 6.85
PWH 166.9 174.2 175.8 172.3 ± 4.74
PWE 175.8 169.4 165.3 170.2 ± 5.29
PPW6 174.2 174.2 166.9 171.8 ± 4.21
PPW7 175.8 176.6 168.5 173.6 ± 4.46
Doxorubicin
CaSki
310.5 306.5 313.7 310.2 ± 3.61
PWM 179.5 193.4 163.9 178.9 ± 14.76
PWH 187.7 213.9 186.1 195.9 ± 15.61
PWE 233.6 229.5 227.0 230.0 ± 3.33
PPW6 173.8 181.1 182.8 179.2 ± 4.78
PPW7 177.0 180.3 171.3 176.2 ± 4.55
Doxorubicin
HT29
236.1 237.7 239.3 237.7 ± 1.60
PWM - P.watsonii crude methanol extract
PWH - P.watsonii crude hexane extract
PWE - P.watsonii crude ethyl acetate extract
PPLM - P.pectinatus (leaves) crude methanol extract
PPLE - P.pectinatus (leaves) crude ethyl acetate extract
PPFE - P.pectinatus (fruits) crude ethyl acetate extract
PPW6 - P.watsonii cytotoxically active fraction
PPW7 - P.watsonii cytotoxically active fraction
245
APPENDIX 6
Cell Cycle Analysis Raw Data
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